Raymond James & Associates’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $49.1M | Buy |
120,759
+5,981
| +5% | +$2.19M | 0.03% | 443 |
|
|
2024
Q2 | $36.9M | Sell |
114,778
-1,861
| -2% | -$605K | 0.02% | 509 |
|
|
2024
Q1 | $38.9M | Sell |
116,639
-24,051
| -17% | -$7.35M | 0.03% | 486 |
|
|
2023
Q4 | $38.1M | Sell |
140,690
-16,173
| -10% | -$4M | 0.03% | 481 |
|
|
2023
Q3 | $38.6M | Sell |
156,863
-2,488
| -2% | -$681K | 0.03% | 431 |
|
|
2023
Q2 | $48.4M | Sell |
159,351
-13,024
| -8% | -$3.62M | 0.04% | 370 |
|
|
2023
Q1 | $45.5M | Buy |
172,375
+2,067
| +1% | +$525K | 0.04% | 388 |
|
|
2022
Q4 | $40.9M | Sell |
170,308
-9,190
| -5% | -$2.06M | 0.04% | 400 |
|
|
2022
Q3 | $33M | Sell |
179,498
-3,299
| -2% | -$657K | 0.03% | 427 |
|
|
2022
Q2 | $30.7M | Buy |
182,797
+43,567
| +31% | +$9.36M | 0.03% | 456 |
|
|
2022
Q1 | $34.9M | Sell |
139,230
-1,204
| -0.9% | -$302K | 0.03% | 475 |
|
|
2021
Q4 | $36.1M | Sell |
140,434
-7,220
| -5% | -$1.77M | 0.03% | 488 |
|
|
2021
Q3 | $35.8M | Buy |
147,654
+14,112
| +11% | +$3.45M | 0.03% | 463 |
|
|
2021
Q2 | $27.6M | Buy |
133,542
+41,104
| +44% | +$8.38M | 0.03% | 551 |
|
|
2021
Q1 | $17.4M | Buy |
92,438
+18,166
| +24% | +$3.2M | 0.02% | 728 |
|
|
2020
Q4 | $12.2M | Sell |
74,272
-23,176
| -24% | -$3.39M | 0.01% | 845 |
|
|
2020
Q3 | $12.2M | Sell |
97,448
-2,101
| -2% | -$260K | 0.02% | 757 |
|
|
2020
Q2 | $9.66M | Buy |
99,549
+29,046
| +41% | +$3.02M | 0.01% | 841 |
|
|
2020
Q1 | $6.33M | Buy |
70,503
+12,143
| +21% | +$1.57M | 0.01% | 932 |
|
|
2019
Q4 | $8.63M | Sell |
58,360
-1,665
| -3% | -$224K | 0.01% | 966 |
|
|
2019
Q3 | $7.23M | Sell |
60,025
-3,330
| -5% | -$430K | 0.01% | 1030 |
|
|
2019
Q2 | $8.56M | Sell |
63,355
-697
| -1% | -$88.1K | 0.01% | 935 |
|
|
2019
Q1 | $8.35M | Buy |
64,052
+4,309
| +7% | +$579K | 0.01% | 907 |
|
|
2018
Q4 | $7.43M | Buy |
59,743
+1,371
| +2% | +$184K | 0.01% | 897 |
|
|
2018
Q3 | $8.12M | Sell |
58,372
-23,111
| -28% | -$2.88M | 0.01% | 950 |
|
|
2018
Q2 | $8.36M | Buy |
81,483
+6,039
| +8% | +$611K | 0.01% | 913 |
|
|
2018
Q1 | $7.32M | Sell |
75,444
-1,346
| -2% | -$131K | 0.01% | 945 |
|
|
2017
Q4 | $6.75M | Sell |
76,790
-9,099
| -11% | -$731K | 0.01% | 966 |
|
|
2017
Q3 | $6.84M | Sell |
85,889
-90,749
| -51% | -$7.3M | 0.01% | 932 |
|
|
2017
Q2 | $15.4M | Sell |
176,638
-1,133
| -0.6% | -$95.9K | 0.03% | 531 |
|
|
2017
Q1 | $15.8M | Buy |
177,771
+3,927
| +2% | +$327K | 0.04% | 488 |
|
|
2016
Q4 | $12.9M | Sell |
173,844
-3,530
| -2% | -$264K | 0.03% | 528 |
|
|
2016
Q3 | $13.4M | Buy |
177,374
+13,780
| +8% | +$1.06M | 0.04% | 483 |
|
|
2016
Q2 | $12.6M | Buy |
163,594
+29,668
| +22% | +$2.34M | 0.04% | 462 |
|
|
2016
Q1 | $10.5M | Buy |
133,926
+19,143
| +17% | +$1.34M | 0.04% | 511 |
|
|
2015
Q4 | $7.76M | Sell |
114,783
-3,224
| -3% | -$225K | 0.03% | 625 |
|
|
2015
Q3 | $9.13M | Buy |
118,007
+3,664
| +3% | +$324K | 0.04% | 519 |
|
|
2015
Q2 | $10.4M | Buy |
114,343
+16,924
| +17% | +$1.36M | 0.04% | 508 |
|
|
2015
Q1 | $7.33M | Buy |
97,419
+6,633
| +7% | +$476K | 0.03% | 574 |
|
|
2014
Q4 | $6.66M | Buy |
90,786
+35,592
| +64% | +$2.5M | 0.03% | 556 |
|
|
2014
Q3 | $3.89M | Sell |
55,194
-4,275
| -7% | -$283K | 0.02% | 746 |
|
|
2014
Q2 | $3.35M | Sell |
59,469
-4,916
| -8% | -$259K | 0.02% | 825 |
|
|
2014
Q1 | $3.38M | Buy |
64,385
+22,409
| +53% | +$1.12M | 0.02% | 749 |
|
|
2013
Q4 | $2M | Buy |
41,976
+24,974
| +147% | +$1.15M | 0.02% | 964 |
|
|
2013
Q3 | $727K | Sell |
17,002
-1,846
| -10% | -$72.1K | 0.01% | 1410 |
|
|
2013
Q2 | $680K | Buy |
+18,848
| New | +$729K | 0.01% | 1356 |
|
Other funds holding HCA
Raymond James & Associates's HCA Position: Q3 2024 in Review
Raymond James & Associates increased its HCA Healthcare (HCA) stake by 5.2% in Q3 2024, buying an estimated $2.19M and bringing the position to 120,759 shares worth $49.1M. The position accounts for 0.03% of the portfolio, ranked #443.
Raymond James & Associates first reported a position in HCA in Q2 2013 and has held it in 46 quarters since. 1,203 funds tracked by Wall St. Rank hold HCA as of Q3 2024.
- Raymond James & Associates held 120,759 shares of HCA Healthcare worth $49.1M as of Q3 2024.
- Raymond James & Associates bought 5,981 HCA Healthcare shares in Q3 2024, an estimated $2.19M.
- HCA Healthcare made up 0.03% of Raymond James & Associates's portfolio in Q3 2024, its #443 holding.
- Raymond James & Associates first reported a position in HCA Healthcare in Q2 2013 and has held it in 46 quarters since.
- 1,203 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.